Merit Medical Systems, Inc. (MMSI) Guidance & Earnings Results
On 2026-07-30 Merit Medical Systems, Inc. raised guidance: "Increased 2026 revenue and non-GAAP EPS guidance; specific numbers not provided in…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MMSIMerit Medical Systems, Inc.Follow MMSI — free
—
Price chart with a free account
- Market cap
- 5.6B
- P/E TTM
- 38.4
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 30 Jul 26 | Raised | Increased 2026 revenue and non-GAAP EPS guidance; specific numbers not provided in excerpt. · full year |
| 24 Feb 26 | Raised | FY2026 revenue $1.610-1.630B (6-8% growth), non-GAAP EPS $4.01-4.15 (5-8% growth) |
| 30 Oct 25 | Raised | Increased 2025 revenue and non-GAAP EPS guidance · full year |
| 30 Jul 25 | Raised | FY2025 revenue raised to $1.495-1.507B from $1.480-1.501B; non-GAAP EPS raised to $3.52-3.72 from $3.28-3.41; Cardiovascular segment $1.423-1.434B from $1.407-1.426B; Endoscopy segment $72.0-73.0M from $73.0-75.0M · full year |
Merit Medical Systems, Inc. — questions
- What guidance did Merit Medical Systems, Inc. give?
- On 2026-07-30: "Increased 2026 revenue and non-GAAP EPS guidance; specific numbers not provided in excerpt."
- When does Merit Medical Systems, Inc. report earnings?
- Merit Medical Systems, Inc.'s next earnings report is expected on 2026-10-29.
Every figure on this page comes from Merit Medical Systems, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.